Company Filing History:
Years Active: 2014
Title: Kevin M Ward: Innovator in the PTEN/AKT Pathway
Introduction
Kevin M Ward is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in understanding the PTEN/AKT pathway. His work has implications for therapeutic targets in various disorders.
Latest Patents
Kevin M Ward holds a patent titled "EEF2K as modifiers of the PTEN/AKT pathway and methods of use." This patent identifies human EEF2K genes as modulators of the PTEN/AKT pathway, highlighting their potential as therapeutic targets for disorders associated with defective PTEN/AKT function. The patent also provides methods for identifying modulators of PTEN/AKT by screening for agents that can modulate the activity of EEF2K.
Career Highlights
Kevin is currently employed at Exelixis, Inc., where he continues to advance research in the field. His innovative work has positioned him as a key figure in the exploration of genetic pathways and their therapeutic applications.
Collaborations
Some of his notable coworkers include Arthur Brace and Robert A Blake, who have collaborated with him on various projects related to his research.
Conclusion
Kevin M Ward's contributions to the understanding of the PTEN/AKT pathway through his patent and work at Exelixis, Inc. underscore his role as an influential inventor in biotechnology. His research holds promise for future therapeutic advancements.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.